AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
SRx Health Solutions receives notice from NYSE American, must regain compliance by July 14, 2026.
ByAinvest
Friday, Oct 17, 2025 8:05 am ET1min read
• SRx Health Solutions received notice from NYSE American LLC for non-compliance.
• Company must have $4 million in stockholders' equity by July 2026.
• SRx Health has until November 13, 2025, to submit a plan of action.
• Receipt of notice has no immediate effect on listing or trading.
SRx Health Solutions, Inc. (NYSE American: SRXH) has received a notice from NYSE American LLC indicating that the company is not in compliance with the exchange's continued listing standards under Section 1003(a)(ii) of the NYSE American Company Guide, according to a GlobeNewswire release . The notice, detailed in the notification letter , was received on October 17, 2025, and specifies that the company must have stockholders' equity of $4 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.The company has been given until November 13, 2025, to submit a plan detailing the actions it will take to regain compliance with the Exchange's continued listing standards by the Plan Period Deadline of July 14, 2026. The receipt of the notice has no immediate effect on the listing or trading of SRx Health's common stock on the Exchange, nor does it impact the company's business operations or reporting requirements with the U.S. Securities and Exchange Commission.
Forward-looking statements included in the press release highlight the company's current expectations and projections about future events and financial trends. However, it is important to note that some or all of the results anticipated by these forward-looking statements may not be achieved.
SRx Health Solutions, Inc. has until November 13, 2025, to submit a plan of action to address the compliance issue. The company's Chief Executive Officer, Kent Cunningham, and Investor Contact, Valter Pinto, are available for further information.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet